SOL-578

N/A

Report date: 2025/01/06 14:18:26
NME

Base Information

Drug NameSOL-578
Drug Alias NamePEP-07SOL-578
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 1 inhibitors
TargetsCheckpoint kinase 1
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma, Mantle-Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSentinel Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPharmaengine Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLymphoma, Mantle-Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A